臨床醫學研究所

Medicine & Life Sciences

1. Taiwan 100%
2. Neoplasms 34%
3. Meta-Analysis 33%
4. Stroke 31%
5. Cohort Studies 28%
6. Population 28%
7. Confidence Intervals 25%
8. Therapeutics 23%
9. Apoptosis 21%
10. Chronic Renal Insufficiency 21%
11. Atrial Fibrillation 19%
12. Systematic Reviews 19%
13. Pulmonary Veins 18%
14. Arsenic 18%
15. Randomized Controlled Trials 18%
16. Odds Ratio 18%
17. Neoplasm Metastasis 18%
18. Genes 18%
19. Hepatocellular Carcinoma 17%
20. Kidney 17%
21. Breast Neoplasms 17%
22. Mortality 16%
23. Colorectal Neoplasms 15%
24. Proteins 15%
25. Bipolar Disorder 15%
26. Renal Dialysis 15%
27. Down-Regulation 14%
28. Biomarkers 13%
29. Cardiac Myocytes 13%
30. Reactive Oxygen Species 12%
31. Lung 12%
32. Incidence 12%
33. Serum 12%
34. Wounds and Injuries 12%
35. Databases 12%
36. Schizophrenia 11%
37. Inflammation 11%
38. Lung Neoplasms 11%
39. In Vitro Techniques 11%
40. Calcium 11%
41. MicroRNAs 11%
42. Autophagy 11%
43. National Health Programs 10%
44. Gene Expression 10%
45. Growth 10%
46. Neoplastic Stem Cells 10%
47. Survival 10%
48. Chronic Obstructive Pulmonary Disease 10%
49. Carcinoma 10%
50. Up-Regulation 9%
51. Non-Small Cell Lung Carcinoma 9%
52. Prostatic Neoplasms 9%
53. Drug Therapy 9%
54. Catenins 9%
55. Endothelial Cells 9%
56. Methylation 9%
57. Epithelial-Mesenchymal Transition 9%
58. Heme Oxygenase-1 9%
59. Lipopolysaccharides 9%
60. Mesenchymal Stem Cells 9%
61. Oxidative Stress 9%
62. Cell Line 8%
63. Macrophages 8%
64. Hyperoxia 8%
65. Peroxisome Proliferator-Activated Receptors 8%
66. Nitric Oxide 8%
67. Cell Movement 8%
68. Sleep 8%
69. Retrospective Studies 8%
70. Metabolic Syndrome 8%
71. Fibrosis 8%
72. Case-Control Studies 8%
73. Hypertension 8%
74. Dialysis 8%
75. ErbB Receptors 8%
76. Cell Proliferation 8%
77. Recurrence 8%
78. Mouth Neoplasms 8%
79. Colonic Neoplasms 7%
80. Pharmaceutical Preparations 7%
81. Blood Pressure 7%
82. Ovarian Neoplasms 7%
83. Pneumonia 7%
84. Diabetes Mellitus 7%
85. Fibroblasts 7%
86. Safety 7%
87. Liver 7%
88. Chronic Kidney Failure 7%
89. Mutation 7%
90. Triple Negative Breast Neoplasms 7%
91. Quality of Life 7%
92. Angiotensin II 7%
93. Messenger RNA 7%
94. Antioxidants 7%
95. Extracellular Signal-Regulated MAP Kinases 7%
96. Glioblastoma 7%
97. Dementia 7%
98. Bone and Bones 7%
99. Elderly 7%
100. Skin 6%